ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Avirmax Inc., will make three scientific presentations at the 2025 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Salt Lake City, Utah, May 4 - 8, 2025. ARVO is the ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 ...

The fight continues against the invasive spread of wild boar in Alberta and its inherent disease risk and damage to the ...

International Business Machines Corporation ( NYSE: IBM) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Olympia McNerney - Global Head of IR Arvind Krishna - Chairman, President and CEO ...

AppLovin shares have recently been in the spotlight, but not in a good way. Check out why I rate APP stock a buy.

Zuckerberg worried about Google diving into social media, and created a competitive buffer around Meta through M&A, according ...

In this powerful reflection, Debra Lee shares her journey from “the good girl” to a trailblazing CEO, revealing the ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Recently, the first-ever OpenHarmony Technical Forum in Europe successfully concluded in Rotterdam, the Netherlands. Centered on the theme of “OpenHarmony Technology Innovation and Ecosystem Practice, ...